what is maintenance dose for tirzepatide chart: complete dosing schedule weight loss Low-Dose Tirzepatide Maintenance: Guide to

Primary Clinical Uses Zepbound is used in several key areas of metabolic health: Chronic Weight Management The primary indication is long-term weight reduction in individuals who struggle to lose weight through diet and exercise alone

Serious Adverse Events: Pancreatitis, Thyroid Risk, and Gallbladder Complications While rare, tirzepatide carries FDA warnings for acute pancreatitis, medullary thyroid carcinoma (MTC), and thyroid C-cell hyperplasia in animal studies

Symptomatic gallstones or acute gallbladder disease require specialist clearance before starting

Semaglutide for weight management (Wegovy) is FDA-approved only for adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia